DiabetesSource

Sulfonyureas secretagogues are longer-acting; workload is increased on the pancreas for a longer period and can cause beta cell burnout. Also available in combination products.

Amaryl® (glimepiride) Sanofi Amaryl® is an orally administered, once-daily hypoglycemic sulfonylurea indicated in the treatment of type 2 diabetes, in association with exercise and a ...More
DiaBeta® (glyburide USP) Sanofi DiaBeta® is an oral blood-glucose-lowering drug indicated as an adjunct to diet to lower the blood glucose in patients with non-insulin-dependent diabetes ...More
DIABINESE® (chlorpropamide) Tablets, USP Pfizer, Inc. DIABINESE® (chlorpropamide) Tablets are an oral blood-glucose-lowering drug of the sulfonylurea class. Indicated as an adjunct to diet to lower the blood ...More
GLUCOTROL XL® (glipizide) Extended Release Tablets Pfizer, Inc. GLUCOTROL XL® is an extended-release oral blood-glucose-lowering drug of the sulfonylurea class. Indicated as an adjunct to diet for the control of ...More
GLUCOTROL® (glipizide) Tablets Pfizer, Inc. GLUCOTROL® is an oral blood-glucose-lowering drug of the sulfonylurea class. Indicated as an adjunct to diet for the control of hyperglycemia and its ...More
Micronase® (gluburide) Tablets, USP. Pfizer, Inc. Micronase® is an oral blood-glucose-lowering drug of the sulfonylurea class. Indicated as an adjunct to diet to lower the blood glucose in patients with ...More